New horizons in the diagnosis and management of patients with MASLD

Eur J Intern Med. 2024 Apr:122:1-2. doi: 10.1016/j.ejim.2024.01.038. Epub 2024 Feb 12.

Authors

Karel J van Erpecum¹, George N Dalekos²

Affiliations

¹ Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Po Box85500, Utrecht, the Netherlands. Electronic address: k.j.vanerpecum@umcutrecht.nl.
² Department of Medicine and Research Laboratory of Internal Medicine, Expertise Center of Greece in Autoimmune Liver Diseases, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), General University Hospital of Larissa, Larissa, Greece.

PMID: 38350783
DOI: 10.1016/j.ejim.2024.01.038

No abstract available

Keywords: Metabolic dysfunction-associated steatohepatitis; Metabolic dysfunction-associated steatotic liver disease; Nomenclature.

Publication types

Editorial